Biogen Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	9,891	9,676	9,836	10,173	10,982
Revenue	9,891	9,676	9,836	10,173	10,982
Revenue Growth (YoY)	2.22%	-1.62%	-3.32%	-7.36%	-18.32%
Cost of Revenue	2,082	2,129	2,533	2,278	2,110
Gross Profit	7,808	7,547	7,302	7,895	8,872
Selling, General & Admin	2,434	2,387	2,502	2,409	2,680
Research & Development	1,753	1,954	2,442	2,229	2,497
Amortization of Goodwill & Intangibles	507.1	386.5	240.6	246.3	252
Other Operating Expenses	290.2	254.4	218.8	-7.4	7.2
Operating Expenses	4,984	4,982	5,403	4,877	5,436
Operating Income	2,824	2,566	1,899	3,019	3,436
Interest Expense	-267.5	-250.3	-246.9	-246.6	-250.4
Interest & Investment Income	125	67.6	276.5	89.3	11
Earnings From Equity Investments	-	-	-	2.6	34.9
Currency Exchange Gain (Loss)	-28.6	-30.9	-50.4	-35.5	-22.4
Other Non Operating Income (Expenses)	-110.1	-26.5	-1.7	-7.1	-4
EBT Excluding Unusual Items	2,543	2,325	1,876	2,821	3,205
Merger & Restructuring Charges	-295.3	-258.2	-271.7	-131.1	-
Gain (Loss) on Sale of Investments	-19.7	-100.4	-291.2	1,228	-824.9
Gain (Loss) on Sale of Assets	-	88.6	-	503.7	-
Asset Writedown	-60.8	-60.2	-	-119.6	-629.3
Legal Settlements	-104.9	-	-	-917	-
Other Unusual Items	-33.6	-27.7	-	209.1	47.5
Pretax Income	1,557	1,906	1,297	3,594	1,780
Income Tax Expense	263.6	273.8	135.3	632.8	52.5
Earnings From Continuing Operations	1,293	1,632	1,162	2,962	1,728
Minority Interest in Earnings	-	-	-0.4	85.3	-171.5
Net Income	1,293	1,632	1,161	3,047	1,556
Net Income to Common	1,293	1,632	1,161	3,047	1,556
Net Income Growth	-20.79%	40.57%	-61.89%	95.80%	-61.10%
Shares Outstanding (Basic)	147	146	145	145	149
Shares Outstanding (Diluted)	147	146	146	146	150
Shares Change (YoY)	0.82%	0.21%	-0.27%	-2.41%	-7.25%
EPS (Basic)	8.83	11.21	8.02	20.97	10.44
EPS (Diluted)	8.79	11.18	7.97	20.87	10.40
EPS Growth	-21.38%	40.28%	-61.81%	100.67%	-58.06%
Free Cash Flow	2,051	2,722	1,270	1,144	3,382
Free Cash Flow Per Share	13.94	18.66	8.72	7.84	22.61
Gross Margin	78.95%	78.00%	74.24%	77.61%	80.79%
Operating Margin	28.55%	26.51%	19.30%	29.67%	31.29%
Profit Margin	13.07%	16.87%	11.80%	29.95%	14.17%
Free Cash Flow Margin	20.73%	28.13%	12.91%	11.24%	30.80%
EBITDA	3,604	3,239	2,394	3,537	3,923
EBITDA Margin	36.44%	33.47%	24.34%	34.77%	35.73%
D&A For EBITDA	779.9	673.2	494.8	518.4	487.7
EBIT	2,824	2,566	1,899	3,019	3,436
EBIT Margin	28.55%	26.51%	19.30%	29.67%	31.29%
Effective Tax Rate	16.93%	14.37%	10.43%	17.61%	2.95%
Revenue as Reported	9,891	9,676	9,836	10,173	10,982
Advertising Expenses	71.9	66.8	71.4	54.1	98.7

Updated Feb 6, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q